Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
about
Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their ReceptorsToll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice.Toll-like receptor 9 mediated responses in cardiac fibroblastsEarly life exposure to air pollution induces adult cardiac dysfunction.Ly6C(low) and not Ly6C(high) macrophages accumulate first in the heart in a model of murine pressure-overload.Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO MiceProinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice.Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes.Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overloadIn vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction.Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms.Myocyte signalling in leucocyte recruitment to the heart.Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation.Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice.Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis.The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling.Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury.
P2860
Q27326691-68616810-29B4-4CAF-A87F-00732F8C3D16Q33604761-8DD7A41C-16DD-4DBC-BD6B-F86A95AF47DDQ34050642-8B1B4B06-83BC-4CCA-BA37-FD2D5926842DQ34439962-15E6822F-50EA-44BF-BE34-72E6869B26E9Q34557178-84FFBE23-BF49-4AD2-8098-531037199DE9Q35804806-FEC8A0E2-32CA-49EA-B6B3-4CA5DB2C0C9EQ35889971-6D04ECF1-E564-4B68-92E0-37B01DA73956Q36013581-06C3160C-1634-4F80-817A-6FC15E537C35Q36830845-56B68151-392B-4C3E-9337-2AD4961DD98DQ36830961-208DEE1C-79F1-40DA-A5E4-9217B275B5F1Q37600036-6C5B68B2-4FE2-4462-AA9C-83FFFF8921DAQ38185647-5A839BDB-5E37-4964-9468-7538B5F3D18EQ38325712-3627E672-7636-40D3-BB44-86FEE413404BQ38906321-37ADE24F-ADF3-420A-AB06-13CBBA5CD83DQ41974755-E6DD624E-4282-46EB-ADB7-10503ED4BC70Q41976316-2D67B19D-2CCA-4B3D-B2CE-60EAE621440DQ42152227-739CACFF-AB3F-415D-AA29-9D50E09BF279Q42229057-EDFA317F-AE20-4066-804F-D2EF93862ED8Q44853398-D504D155-3856-4624-AF56-FD2C77E6D4F1Q47422758-1E28CF10-9747-44C1-9823-BD6421BC5354Q52632607-1E91C76C-C8CC-4109-89B9-1B74D890075DQ55003428-280330C2-6418-4403-8B3F-A4CF5B147E87Q55155611-191F20EB-7FE2-4716-85AB-A82EBA646F93Q55366238-FA7E682D-409D-4BF3-952E-2A9549B0BFE7
P2860
Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@en
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@nl
type
label
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@en
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@nl
prefLabel
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@en
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@nl
P2093
P2860
P356
P1476
Priming with synthetic oligonu ...... d cardiac hypertrophy in mice.
@en
P2093
Andreas Hoeft
Georg Baumgarten
Georg D Duerr
Jan Mersmann
Julia Schild
Kai Zacharowski
Markus Velten
Olaf Boehm
Oliver Dewald
Pascal Knuefermann
P2860
P304
P356
10.1093/CVR/CVS280
P577
2012-09-12T00:00:00Z